-Reuters
Piper Sandler Maintains Overweight on I-MAB, Lowers Price Target to $30
Piper Sandler analyst Joseph Catanzaro maintains I-MAB (NASDAQ:IMAB) with a Overweight and lowers the price target from $35 to $30.
Related Posts
Goldman Sachs, JP Morgan, Wells Fargo, Among Major US Banks To Write Off $5Bn In Loans: Report
The six largest banks in the US, namely JP Morgan Chase (NYSE:MS), are projected to write off a…
VEON Is The Sole And Rightful Owner Of Kyivstar, Co Responds To Speculation About Kyivstar
VEON Ltd. (NASDAQ:VEON, Euronext Amsterdam: VEON)))), a global digital operator that provides converged connectivity and online services, issues the following clarification regarding the developments in Ukraine, in
Reddit Co-Founder Alexis Ohanian Shares Task Management Tips, It’s Not A ‘Set Of Hard Rules That Can’t Be Changed’
Alexis Ohanian, Reddit's co-founder, emphasized the importance of flexibility and transparency in task management for startup founders, countering the common misconception that it requires rigid rules.